HomeHealth NewsFDA approves Wegovy-like GLP-1 pill, Foundayo, for weight loss

FDA approves Wegovy-like GLP-1 pill, Foundayo, for weight loss

April 9, 2026

- Advertisement -

Could a new oral option help to meet the growing demand for GLP-1 medications? Image Credit: Medical News Today/Photo by Eli Lilly

The Food and Drug Administration (FDA) has approved Eli Lilly’s Foundayo (orforglipron), a once-daily oral glucagon-like peptide-1 (GLP-1) receptor agonist, which offers a noninjectable option for weight management.
Clinical data suggests the drug supports meaningful weight loss and can be taken without strict food or timing requirements, potentially improving…

- Advertisment -